The global market for Single-use Technologies in Biopharmaceuticals expected to reach $4.3 billion by 2021

NEW YORK, June 26, 2017 /PRNewswire/ -- Highlights

·         The global market for single-use technology reached $2.7 billion in 2016. The market should reach over $4.3 billion by 2021, growing at a compound annual growth rate (CAGR) of 10.1% from 2016 to 2021.

·         The United States market for single-use technology reached $1.1 billion in 2016. The market should reach $2.0 billion by 2021, growing at a CAGR of 12.3% from 2016 to 2021.

·         The European market for single-use technology reached $806.3 million in 2016. The market should reach $1.3 billion by 2021, growing at a CAGR of 9.2% from 2016 to 2021.

·         Single-use technologies can be used from upstream through downstream bioprocessing and in formulations and fillings.

·         In recent years, the focus of the manufacturers has been on improving the efficiency and effectiveness of production, and single-use technology supports this need.

·         Over the past few years, several manufacturers have implemented single-use systems in comparison to stainless steel equipment in their production process.

·         BCC Research's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for single-use technology products.

·         A detailed analysis of the industry structure has been conducted. The revenues have been broken down by region and sales have been estimated for the five-year period from 2016 through 2021.

·         Market by applications and by end users is also discussed separately in the report, with emphasis on the usage of these type technologies in various biopharmaceutical productions.

- The global market for single-use technology reached $2.7 billion in 2016. The market should reach over $4.3 billion by 2021, growing at a compound annual growth rate (CAGR) of 10.1% from 2016 to 2021.

- The United States market for single-use technology reached
$1.1 billion in 2016. The market should reach $2.0 billion by 2021, growing at a CAGR of 12.3% from 2016 to 2021.
- The European market for single-use technology reached
$806.3 million in 2016. The market should reach $1.3 billion by 2021, growing at a CAGR of 9.2% from 2016 to 2021.

Study Goals and Objectives
Single-use technologies can be used from upstream through downstream bioprocessing and in formulations and fillings. In recent years, the focus of the manufacturers has been on improving the efficiency and effectiveness of production, and single-use technology supports this need. Over the past few years, several manufacturers have implemented single-use systems in comparison to stainless steel equipment in their production process.

BCC Research's goal in conducting this study is to provide an overview of the current and future characteristics of the global market for single-use technology products.

This report explores present and future strategies within the single-use technology market, which includes categories such as, single-use bioreactors, membrane adsorbers, media bags, tubing and connectors, bioprocess containers, disposable mixing systems, samplers, filter cartridges, depth filtration, tangential flow filtration and other single-use products that include clamps, valves, prepacked mini columns. The improvisation of the market, the setbacks and the needs of the market are discussed in this report. The classifications, comparisons and usage of these types of technology products are also portrayed in this report.

A detailed analysis of the industry structure has been conducted. The revenues have been broken down by region and sales have been estimated for the five-year period from 2016 through 2021.

Market by applications and by end users is also discussed separately in the report, with emphasis on the usage of these type technologies in various biopharmaceutical productions. The report also covers significant patents and their allotments in each category.

Reasons for Doing This Study
Single-use technology products are significantly changing the bioprocessing and biopharmaceutical industry by reducing the product development timeline, reducing the costs of labor, material and utilities, increasing process efficiency, increasing productivity and reducing risk of cross-contamination. Recently, single-use products have become an essential part of the pharmaceutical industry and shown significant growth in the last decade. These products are commercially used for bioproduction of vaccines, drugs, antibodies, and various other biomolecules.

R&D spending, along with increasing competition, patent expiries and new technologies, are directing the market. The advancements and new product launches have influenced market growth. This study looks at almost all the systems affected by these factors.

Acquisition strategies and collaborations are also covered in this report, along with the strengths and weaknesses of each type in light of new technologies, growing competition, and changing customer needs.

Intended Audience
This study contributes to the areas of market growth in single-use technology products, manufacturers and users. Research centers, academic institutions, government and private laboratories, hospitals, as well as pharmaceutical, diagnostic and biotechnology companies will find this study to be of interest.

Scope of Report
The rise in the number of diseases, need for newer medicines and advances in technology have augmented growth in the biopharmaceutical industry. Single-use technology has become an essential part of the bioprocessing industry over the past decade. This report focuses on the global market of single-use technology products and provides review including its applications in various arenas.

The scope of the study is global. BCC Research analyzes each market and its application, regulatory environment, new products and advancements, market projections and market shares. The report covers market of single-use products by the end user and applications.

The end users for single-use products are categorized as biopharmaceutical manufacturers and contract manufacturing organizations. The report covers market application areas, such as monoclonal antibodies (mAbs), vaccines, gene therapy, recombinant proteins, blood derivatives and anti-cancer drugs. The geographical regions covered in the report are the United States, Europe and Emerging markets. The emerging market covers countries including India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand, and Canada among others.

Also included in the report are relevant patent analysis, new products and developments and comprehensive profiles of companies that lead the industry. The key market players are Thermo Fischer Scientific, Danaher Corp., EMD Millipore, and Sartorius Stedim Biotech.

Information Sources
Many companies were surveyed to obtain data for this study. Included were manufacturers and end users of single-use technology products. Data was gathered from various industry sources. BCC Research spoke with officials within the industry, consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.

Methodology
Both primary and secondary research methodologies were used in preparing this study. BCC Research conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with manufacturers and users of single-use technology products. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

Geographic Breakdown
In this report, the geographic regions considered for market analysis include, and only include:
- United States
- Europe
- Emerging Markets

Summary and Highlights
Single-use technology products are playing a pivotal role in the biopharmaceutical industry. The expanding field of biopharmaceuticals is allowing manufacturers to focus on single-use technology products, which play important roles in the bioprocessing of a large number of products like vaccines, drugs, antibodies and proteins. With the rise of infectious diseases, there is an urgent need for better healthcare conditions to treat diseases.

The production of biopharmaceuticals requires handling living organisms and thus requires cleaning and sterilization to eliminate contaminants. In addition, the raw materials required for bioproduction need to undergo a quality check. With the change in healthcare systems around the world, there is an increased demand for drugs at reduced prices. This has resulted in the creation of pioneering techniques such as single-use technology to reduce capital investment without sacrificing production rates and quality.

In the last decade, the overall single-use technology market has witnessed a tremendous increase in the usage of novel products. The focus of the companies is to enhance the production of life saving moieties by using advancement in technologies in order to provide better quality of treatment and therapies. In addition, increased government spending in biopharmaceutical sector is also expected to support the growth of the market.

The single-use technology market includes single-use bioreactors, membrane adsorbers, disposable filter cartridges, tubing and connectors, media bags, bioprocess containers, depth filtration systems, tangential flow filtration systems, samplers, single-use mixers and other single-use products. The major end users of these products are research centers, government and private laboratories, as well as pharmaceutical, biotechnology companies and the healthcare sector.

Major manufacturers of single-use products are Danaher Corp., Merck Millipore, Sartorius Stedim Biotech, GE Healthcare, Thermo Fisher Scientific and VWR International Co.

The global market for single-use technology is anticipated to increase at a CAGR of 10.1% and is expected to be around $4.3 billion in 2021. Single-use bioreactors are expected to be the largest segment in terms of revenues through 2021. The use of single-use systems could be further boosted in coming years as demand for therapeutic drugs increases due to more incidences of specific health conditions.

Sales in the U.S. market during the observed period were noteworthy. Europe and emerging markets also had significant shares in the market. Rise in research expenditure, deterioration in human health conditions and the need for novel and effective drugs have augmented the demand for single-use products in the biopharmaceutical sector.

Emerging markets for single-use technologies are expanding. The major flourishing markets include India, China and South Korea. Increasing demand for better treatment facilities in Asian countries have increased research and development activities within the biopharmaceutical field, hence increasing the market of these products.

Single-use products are widely used in biopharmaceutical manufacturing. Vaccines and monoclonal antibodies have the highest revenues due to the involvement of single-use technology in the production of various vaccines and antibodies. The market for single-use technology in vaccines and monoclonal antibodies is expected to grow at a CAGR of 9.6% and 11.0% respectively in 2021.
Read the full report: http://www.reportlinker.com/p01057702/Single-Use-Technologies-for-Biopharmaceuticals-Global-Markets.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-global-market-for-single-use-technologies-in-biopharmaceuticals-expected-to-reach-43-billion-by-2021-300479765.html

SOURCE Reportlinker